Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
Clinical trial NCT00978497 · COMPLETED
Trial details
- NCT number
- NCT00978497
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.